Exhaled leukotriene B4 and community acquired pneumonia in children
S. Carraro, B. Andreola, L. Da Dalt, S. Callegaro, R. Alinovi, C. Corradi, E. Baraldi (Padova, Parma, Italy)
Source: Annual Congress 2006 - Pneumonia and other invasive pulmonary infections in children
Abstract Rationale : The alveolar infiltrate in pneumonia is characterized by a high number of activated neutrophils, for which leukotriene B4 (LTB4) is a strong activating and chemotactic agent. Exhaled breath condensate (EBC) is a safe and non-invasive technique that allows the study of lower airways. The present study was conducted to measure EBC LTB4 as a potential non-invasive marker of the inflammatory response which occurs in community acquired pneumonia (CAP). Methods: 11 children with CAP were recruited. They underwent physical examination, chest X-ray and a blood sample was drawn to measure leukocyte count and C-reactive protein. Moreover, children performed spirometry and EBC collection using a refrigerating system supplied with disposable device (Turbo DECCS, Parma, Italy). EBC collection and spirometry were repeated after one week of antibiotic therapy and one month later. LTB4 levels were assessed using an EIA system (Amersham Biosciences).Results : LTB4 EBC concentrations were increased in the acute phase of CAP (mean + SEM: 14.8 + 2.0 pg/ml) and decreased significantly after one week of antibiotic therapy (6.0 + 1.4 pg/ml, p<0.001). No further reduction was demonstrated one month later (5.4 + 1.7 pg/ml, p=ns). Spirometry demonstrated a restrictive pattern in the acute phase (mean FEV1 67% pred, mean FVC 65% pred) and improved significantly one week later (mean FEV1 81% pred, mean FVC 81% pred, p<0.01). Conclusion : LTB4 concentrations are increased in EBC of children with CAP and decrease after a course of antibiotic therapy. Our findings suggest that LTB4 is involved in the inflammatory response which characterizes CAP. EBC may represent a new approach to study the pathophysiology of deep lung infections.
Rating:
You must login to grade this presentation.
Share or cite this content
Citations should be made in the following way:
S. Carraro, B. Andreola, L. Da Dalt, S. Callegaro, R. Alinovi, C. Corradi, E. Baraldi (Padova, Parma, Italy). Exhaled leukotriene B4 and community acquired pneumonia in children. Eur Respir J 2006; 28: Suppl. 50, 1795
You must login to share this Presentation/Article on Twitter, Facebook, LinkedIn or by email.
Member's Comments
Related content which might interest you:
Related content which might interest you:
Increased exhaled cysteinyl-leukotrienes, leukotriene B4 and 8-isoprostane in exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Cysteinyl leukotrienes and leukotriene B4 in expired breath condensate in patients with chronic asthma treated with montelukast Source: Eur Respir J 2003; 22: Suppl. 45, 101s Year: 2003
Urinary leukotriene E4 and exhaled nitric oxide on recovery from exercise-induced bronchospasm in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 259s Year: 2006
Leukotriene B4 levels in sputum from asthma patients Source: ERJ Open Res, 2 (4) 00088-2015; 10.1183/23120541.00088-2015 Year: 2016
Corticosteroid reversibility testing and exhaled leukotriene B4 in patients with stable, severe COPD Source: Eur Respir J 2002; 20: Suppl. 38, 252s Year: 2002
Increased urinary leukotriene E4 concentration in patients with eosinophilic pneumonia Source: Eur Respir J 2008; 32: 437-442 Year: 2008
Leukotriene B4 in exhaled breath condensate of patients after lung transplantation Source: Eur Respir J 2001; 18: Suppl. 33, 297s Year: 2001
Saliva is one likely source of leukotriene B4 in exhaled breath condensate Source: Eur Respir J 2006; 28: 1229-1235 Year: 2006
Therapeutical impact of montelukast on exhaled leukotrienes in asthmatic children Source: Eur Respir J 2006; 28: Suppl. 50, 210s Year: 2006
Exhaled leukotrienes B4 and E4 in nonasthmatic patients with seasonal allergic rhinitis in and out of the pollen season Source: Eur Respir J 2005; 26: Suppl. 49, 372s Year: 2005
Exhaled nitric oxide and airway resistance in preschool children with and without respiratory symptoms Source: Annual Congress 2008 - Wheezing in preschool children Year: 2008
Eosinophil activation and cysteinyl leukotriene production in infants with RSV positive bronchiolitis Source: Eur Respir J 2001; 18: Suppl. 33, 180s Year: 2001
Leukotriene B4 in breath condensate in patients with exacerbation of COPD Source: Eur Respir J 2001; 18: Suppl. 33, 248s Year: 2001
Exhaled nitric oxide increases in chronic eosinophilic pneumonia Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002
Exhaled nitric oxide and serum IgE in children admitted to a pediatric department Source: Annual Congress 2012 - Clinical and diagnostic markers and management of paediatric allergic diseases Year: 2012
Exhaled leukotrienes in smoking and non-smoking patients with chronic asthma Source: Annual Congress 2006 - Smoking asthmatics – a neglected population? Year: 2006
Thromboxane B2 and prostaglandin E2 concentrations in exhaled breath condensate in healthy volunteers and patients with bronchial asthma Source: Eur Respir J 2002; 20: Suppl. 38, 509s Year: 2002
Exhaled nitric oxide levels during upper respiratory infections (URI) in young patients with rinasma Source: Eur Respir J 2001; 18: Suppl. 33, 164s Year: 2001
Exhaled nitric oxide in children with severe asthma Source: Annual Congress 2012 - Severe asthma and developing allergy in childhood Year: 2012
Relationship betweeen exhaled nitric oxide and clinical pattern in Community-acquired pneumonia patients Source: International Congress 2017 – Insight into the pathogenesis of emphysema and pneumonia Year: 2017